| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20.1B | $16.7B | $14.2B | $12.7B | $11.9B | $9.9B | $10.7B | $9.8B |
| Cost of Revenue | $6.2B | $5.3B | $4.3B | $4.0B | $3.7B | $3.5B | $3.1B | $2.8B |
| Gross Profit | $13.9B | $11.5B | $9.9B | $8.7B | $8.2B | $6.4B | $7.6B | $7.0B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $6.9B | $6.0B | $5.2B | $4.5B | $4.4B | $3.8B | $3.9B | $3.6B |
| Operating Income | $3.6B | $2.6B | $2.3B | $1.6B | $1.2B | $-0.1B | $1.5B | $1.5B |
| Net Income | $2.9B | $1.8B | $1.6B | $0.7B | $1.0B | $-0.1B | $4.7B | $1.7B |
| EPS (Basic) | $1.96 | $1.26 | $1.08 | $0.45 | $0.69 | $-0.08 | $3.38 | $1.21 |
| EPS (Diluted) | $1.94 | $1.25 | $1.07 | $0.45 | $0.69 | $-0.08 | $3.33 | $1.19 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $43.7B | $39.4B | $35.1B | $32.5B | $32.2B | $30.8B | $30.6B | $21.0B |
| Current Assets | $8.8B | $6.9B | $6.5B | $5.8B | $6.3B | $6.7B | $4.7B | $4.0B |
| Cash & Equivalents | $2.0B | $0.4B | $0.9B | $0.9B | $1.9B | $1.7B | $0.2B | $0.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $5.4B | $6.4B | $4.9B | $3.8B | $4.3B | $3.7B | $4.9B | $5.3B |
| Stockholders' Equity | $24.2B | $21.8B | $19.3B | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.5B | $3.4B | $2.5B | $1.5B | $1.9B | $1.5B | $1.8B | $0.3B |
| Investing Cash Flow | $-2.6B | $-5.7B | $-2.6B | $-2.0B | $-1.6B | $-0.4B | $-5.0B | $-1.9B |
| Capital Expenditures | $0.9B | $0.8B | $0.7B | $0.6B | $0.6B | $0.4B | $0.5B | $0.3B |
| Financing Cash Flow | $-0.4B | $1.8B | $0.0B | $-0.5B | $-0.1B | $0.3B | $3.0B | $1.4B |